Key result
Integrated Pharmacy Transitions of Care fails to reduce 30-day readmissions versus usual care.
Why the study?
The effectiveness of an integrated Pharmacy Transitions of Care program on reducing hospital readmissions and improving patient satisfaction was evaluated.
Does an integrated Pharmacy Transitions of Care program reduce 30-day readmissions in hospital discharged patients?
Comparison
Pharmacy Transitions of Care program vs usual hospital discharge care
Design
Prospective observational cohort study
Follow-up
30-day
Authors
Loading...
Does not support reduced readmissions with pharmacy transitions of care; hypothesis-generating for larger randomized trials.
Cohort (n=795)
No
Does an integrated Pharmacy Transitions of Care program reduce 30-day readmissions in hospital discharged patients?
Absolute Event Rate: 5.7% vs 13.8%
p-value: p=.08
An integrated pharmacy transitions of care program did not significantly reduce 30-day readmissions but improved patient satisfaction and medication understanding.
Christy et al. (2015) conducted a cohort in Hospital discharge (n=795). Integrated Pharmacy Transitions of Care (PTC) pilot program vs. Usual hospital discharged patients was evaluated on 30-day all-cause readmissions (p=.08). An integrated Pharmacy Transitions of Care pilot program did not significantly reduce 30-day all-cause readmissions compared to usual care (5.7% vs 13.8%, P = .08).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: